Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Biocon LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532523NSE Symbol: BIOCONP/E(TTM):0
ISIN Demat:INE376G01013Div & Yield %:0.48EPS(TTM):0.4
Book Value(Rs):90.3831418Market Cap ( Cr.):37344.66Face Value(Rs):5
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 1992.901738.202028.401988.401785.702425.50
Excise Duty0.000.000.000.000.006.30
Net Sales1992.901738.202028.401988.401785.702419.20
Other Income 3134.20187.20150.20366.00422.00124.70
Stock Adjustments -3.20105.80-36.7031.4069.101.80
Total Income5123.902031.202141.902385.802276.802545.70
EXPENDITURE :      
Raw Materials 981.00914.00761.60859.10857.601051.20
Power & Fuel Cost279.20231.00186.00193.30152.40161.00
Employee Cost 433.80367.70390.20344.80289.10408.60
Other Manufacturing Expenses 127.10130.50147.00118.30104.30137.40
Selling and Administration Expenses 112.20106.70128.40208.40222.40325.80
Miscellaneous Expenses 32.9033.0066.009.9018.7018.80
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1966.201782.901679.201733.801644.502102.80
Operating Profit3157.70248.30462.70652.00632.30442.90
Interest 69.600.400.401.202.601.00
Gross Profit3088.10247.90462.30650.80629.70441.90
Depreciation116.90108.20103.5098.0092.30136.10
Profit Before Tax2971.20139.70358.80552.80537.40305.80
Tax132.7060.7073.50104.4054.6060.60
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-9.90-7.104.807.50-9.906.70
Reported Net Profit2848.4086.10280.50440.90492.70238.50
Extraordinary Items 2861.732.923.00136.27166.6425.04
Adjusted Net Profit-13.3383.18277.50304.63326.06213.46
Adjst. below Net Profit 29.40-59.4030.4022.60-51.8017.70
P & L Balance brought forward7132.807106.106795.206391.806020.605824.40
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 60.000.000.0060.1069.4060.00
P & L Balance carried down9950.607132.807106.106795.206392.106020.60
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %30.0010.000.000.0020.0020.00
Earnings Per Share-Unit Curr23.720.722.343.678.213.98
Earnings Per Share(Adj)-Unit Curr23.720.722.343.674.111.99
Book Value-Unit Curr90.9167.4065.8862.80118.58112.30